ABBOTT LABORATORIES
10-Q · 2014-08-05T00:00:00Z · 0001104659-14-05695048 tables
Uncategorized (48)
- R10.htmSupplemental Financial Information
1030 - Disclosure - Supplemental Financial Information
- R11.htmChanges in Accumulated Other Comprehensive Income (Loss)
1040 - Disclosure - Changes in Accumulated Other Comprehensive Income (Loss)
- R12.htmBusiness Acquisitions
1050 - Disclosure - Business Acquisitions
- R13.htmGoodwill and Intangible Assets
1060 - Disclosure - Goodwill and Intangible Assets
- R14.htmRestructuring Plans
1070 - Disclosure - Restructuring Plans
- R15.htmIncentive Stock Programs
1080 - Disclosure - Incentive Stock Programs
- R16.htmFinancial Instruments, Derivatives and Fair Value Measures
1090 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures
- R17.htmLitigation and Environmental Matters
1100 - Disclosure - Litigation and Environmental Matters
- R18.htmPost-Employment Benefits
1110 - Disclosure - Post-Employment Benefits
- R19.htmTaxes on Earnings
1120 - Disclosure - Taxes on Earnings
- R1.htmDocument and Entity Information
0000 - Document - Document and Entity Information
- R20.htmSegment Information
1130 - Disclosure - Segment Information
- R21.htmSubsequent Event
1140 - Disclosure - Subsequent Event
- R22.htmSupplemental Financial Information (Tables)
3030 - Disclosure - Supplemental Financial Information (Tables)
- R23.htmChanges in Accumulated Other Comprehensive Income (Loss) (Tables)
3040 - Disclosure - Changes in Accumulated Other Comprehensive Income (Loss) (Tables)
- R24.htmRestructuring Plans (Tables)
3070 - Disclosure - Restructuring Plans (Tables)
- R25.htmIncentive Stock Programs (Tables)
3080 - Disclosure - Incentive Stock Programs (Tables)
- R26.htmFinancial Instruments, Derivatives and Fair Value Measures (Tables)
3090 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Tables)
- R27.htmPost-Employment Benefits (Tables)
3110 - Disclosure - Post-Employment Benefits (Tables)
- R28.htmSegment Information (Tables)
3130 - Disclosure - Segment Information (Tables)
- R29.htmSeparation of AbbVie Inc. (Details)
4020 - Disclosure - Separation of AbbVie Inc. (Details)
- R2.htmCondensed Consolidated Statement of Earnings
0010 - Statement - Condensed Consolidated Statement of Earnings
- R30.htmSupplemental Financial Information (Details)
4030 - Disclosure - Supplemental Financial Information (Details)
- R31.htmChanges in Accumulated Other Comprehensive Income (Loss) (Details)
4040 - Disclosure - Changes in Accumulated Other Comprehensive Income (Loss) (Details)
- R32.htmBusiness Acquisitions (Details)
4050 - Disclosure - Business Acquisitions (Details)
- R33.htmGoodwill and Intangible Assets (Details)
4060 - Disclosure - Goodwill and Intangible Assets (Details)
- R34.htmGoodwill and Intangible Assets (Details 2)
4061 - Disclosure - Goodwill and Intangible Assets (Details 2)
- R35.htmGoodwill and Intangible Assets (Details 3)
4062 - Disclosure - Goodwill and Intangible Assets (Details 3)
- R36.htmRestructuring Plans (Details)
4070 - Disclosure - Restructuring Plans (Details)
- R37.htmRestructuring Plans (Details 2)
4071 - Disclosure - Restructuring Plans (Details 2)
- R38.htmIncentive Stock Programs (Details)
4080 - Disclosure - Incentive Stock Programs (Details)
- R39.htmFinancial Instruments, Derivatives and Fair Value Measures (Details)
4090 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details)
- R3.htmCondensed Consolidated Statement of Comprehensive Income
0020 - Statement - Condensed Consolidated Statement of Comprehensive Income
- R40.htmFinancial Instruments, Derivatives and Fair Value Measures (Details 2)
4091 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 2)
- R41.htmFinancial Instruments, Derivatives and Fair Value Measures (Details 3)
4092 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 3)
- R42.htmFinancial Instruments, Derivatives and Fair Value Measures (Details 4)
4093 - Disclosure - Financial Instruments, Derivatives and Fair Value Measures (Details 4)
- R43.htmLitigation and Environmental Matters (Details)
4100 - Disclosure - Litigation and Environmental Matters (Details)
- R44.htmPost-Employment Benefits (Details)
4110 - Disclosure - Post-Employment Benefits (Details)
- R45.htmTaxes on Earnings (Details)
4120 - Disclosure - Taxes on Earnings (Details)
- R46.htmSegment Information (Details)
4130 - Disclosure - Segment Information (Details)
- R47.htmSegment Information (Details 2)
4131 - Disclosure - Segment Information (Details 2)
- R48.htmSubsequent Event (Details)
4140 - Disclosure - Subsequent Event (Details)
- R4.htmCondensed Consolidated Statement of Comprehensive Income (Parenthetical)
0025 - Statement - Condensed Consolidated Statement of Comprehensive Income (Parenthetical)
- R5.htmCondensed Consolidated Balance Sheet
0030 - Statement - Condensed Consolidated Balance Sheet
- R6.htmCondensed Consolidated Balance Sheet (Parenthetical)
0035 - Statement - Condensed Consolidated Balance Sheet (Parenthetical)
- R7.htmCondensed Consolidated Statement of Cash Flows
0040 - Statement - Condensed Consolidated Statement of Cash Flows
- R8.htmBasis of Presentation
1010 - Disclosure - Basis of Presentation
- R9.htmSeparation of AbbVie Inc.
1020 - Disclosure - Separation of AbbVie Inc.